Neurofeedback and its possible relevance for the treatment of Tourette syndrome.

Abstract

Neurofeedback is an increasingly recognized therapeutic option in various neuropsychiatric disorders to treat dysfunctions in cognitive control as well as disorder-specific symptoms. In this review we propose that neurofeedback may also reflect a valuable therapeutic option to treat executive control functions in Gilles-de-la-Tourette syndrome (GTS). Deficits in executive control functions when ADHD symptoms appear in GTS likely reflect pathophysiological processes in cortico-thalamic-striatal circuits and may also underlie the motor symptoms in GTS. Such executive control deficits evident in comorbid GTS/ADHD depend on neurophysiological processes well-known to be modifiable by neurofeedback. However, so far efforts to use neurofeedback to treat cognitive dysfunctions are scarce. We outline why neurofeedback should be considered a promising treatment option, what forms of neurofeedback may prove to be most effective and how neurofeedback may be implemented in existing intervention strategies to treat comorbid GTS/ADHD and associated dysfunctions in cognitive control. As cognitive control deficits in GTS mostly appear in comorbid GTS/ADHD, neurofeedback may be most useful in this frequent combination of disorders.

• Authors: Aniko Farkas, Annet Bluschke, Veit Roessner, Christian Beste
• Journal: Neuroscience and biobehavioral reviews (Neurosci Biobehav Rev) Vol. 51 Pg. 87-99 (Apr 2015) ISSN: 1873-7528 [Electronic] United States
• PMID: 25616186 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2015 Elsevier Ltd. All rights reserved.

Topics

• Brain (pathology, physiopathology)
• Humans
• Neurofeedback (methods)
• Tourette Syndrome (pathology, physiopathology, therapy)